Secondary Logo

Journal Logo

Diagnosis of venous thromboembolism using clinical pretest probability rules, D-dimer assays, and imaging techniques

Venous thromboembolism is a significant clinical entity that includes two associated medical disorders: deep vein thrombosis and pulmonary embolism. The goal of this article is to describe the optimal approach to evaluating venous thromboembolism including pretest probability clinical decision rules and appropriate testing to ensure an accurate diagnosis.

Get Content & Permissions

The role of telemedicine in gynecologic healthcare: A narrative review

This article offers a comprehensive narrative literature review on telemedicine use in gynecologic healthcare analyzing current telemedicine integration in the field and outlining innovative and best practices. Telemedicine use in contraceptive care, sexually transmitted infections, acute and chronic gynecologic conditions, and education are discussed. NPs are in a unique position to offer these services to patients in need of women's healthcare services. Barriers, facilitators, clinical implications, and future research are addressed.

Get Content & Permissions

COVID-19 and telehealth: Applying telehealth and telemedicine in a pandemic

In this second article of a three-part series, we explore how stakeholders can be educated on the use of telehealth technology and telemedicine. We address the need for staff and patient support for the transition to telehealth and offer suggestions to NPs for appropriate presentation and interaction with interdisciplinary teams and patients regarding telehealth.

Get Content & Permissions

Quick Poll

A conservative estimate of venous thromboembolism's economic burden to the US healthcare system is X annually for newly diagnosed, medically treated patients.
A conservative estimate of venous thromboembolism's economic burden to the US healthcare system is X annually for newly diagnosed, medically treated patients.
A conservative estimate of venous thromboembolism's economic burden to the US healthcare system is X annually for newly diagnosed, medically treated patients.
A conservative estimate of venous thromboembolism's economic burden to the US healthcare system is X annually for newly diagnosed, medically treated patients.
A conservative estimate of venous thromboembolism's economic burden to the US healthcare system is X annually for newly diagnosed, medically treated patients.
 Submit
 Clear
 Results